title: Thymus hormones do not induce proliferative ability or cytolytic function in PNA+ cortical thymocytes.
abstract: A variety of thymus hormone preparations, as well as drugs known to perturb cell differentiation, were tested for their ability to induce nonfunctional cortical thymocytes to become functional precursor cells. Murine cortical thymocytes, defined as the high peanut agglutinin (PNA) binding or as the low H-2K, major [86%] thymocyte subpopulation, were isolated by fluorescence-activated cell sorting. Their function was assessed in a high cloning efficiency, growth factor saturated, concanavalin A-stimulated limit-dilution culture system, determining the number of precursors of extended clones (PTL-p), or determining with a lectin-mediated tumor-lysis readout the number of precursors of cytolytic clones (CTL-p). The hormone preparations tested were crude or partially purified culture supernatants from thymus "epithelial" monolayers (TES), soluble extracts of thymic nonlymphoid tissue (STF), semipure thymus humoral factor (THF), and the pure peptides thymopoietin 32-36 (TP5) and "facteur thymique sérique" (FTS). These preparations were either added directly to the limit dilution cultures, or were first preincubated with the cells, which were then subjected to limit-dilution culture. In no case did the hormone preparations cause any increase in the level of PTL-p or CTL-p in the PNA+ or low H-2K thymocyte population, even though a conversion of only a few percent to functional cells could have been detected. Two possible explanations are considered. One is that the main function of these materials is to control post-thymic peripheral T cells, rather than to induce intrathymic differentiation. Another is that the typical cortical thymocyte is beyond the stage at which thymocytes can be induced by hormones, a view that is strengthened by the failure of either 5-azacytidine or the phorbol ester 12-O-tetradecanoyl phorbol 13-acetate to activate these cells. In this latter explanation the true intrathymic target of hormone action may be an earlier, and very minor, thymus subpopulation.
authors.forename: P
authors.initials: P
authors.lastname: Andrews
authors.forename: K
authors.initials: K
authors.lastname: Shortman
authors.forename: R
authors.initials: R
authors.lastname: Scollay
authors.forename: E F
authors.initials: EF
authors.lastname: Potworowski
authors.forename: A M
authors.initials: AM
authors.lastname: Kruisbeek
authors.forename: G
authors.initials: G
authors.lastname: Goldstein
authors.forename: N
authors.initials: N
authors.lastname: Trainin
authors.forename: J F
authors.initials: JF
authors.lastname: Bach
mesh_terms: D000818:Animals; D001374:Azacitidine / Q000494:pharmacology; D002478:Cells, Cultured; D006183:H-2 Antigens; D037102:Lectins / Q000276:immunology; D008213:Lymphocyte Activation / Q000187:drug effects; D051379:Mice; D019887:Peanut Agglutinin; D013601:T-Lymphocytes / Q000187:drug effects* / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D013935:Thymic Factor, Circulating / Q000494:pharmacology; D013951:Thymus Hormones / Q000494:pharmacology*
chemical_list: D006183:H-2 Antigens; D037102:Lectins; D019887:Peanut Agglutinin; D013951:Thymus Hormones; C014859:thymic humoral factor; D013935:Thymic Factor, Circulating; D001374:Azacitidine; D013755:Tetradecanoylphorbol Acetate